Correct answer = C.
The pathology of IPF demonstrates areas of normal lung parenchyma, areas of active inflammation, and areas of end-stage fibrotic lung all within the same patient at the same point in time. Hence, transbronchial biopsy, with the small quantity of lung tissue obtained and the high likelihood of a sampling error, is often inadequate for diagnosing IPF and open-lung biopsy is often required. High resolution CT shows a characteristic pattern of bibasilar peripheral fibrosis with or without evidence of alveolar inflammation; typically there is no pleural involvement and no pleural effusion. Treatment with steroids and/or cytotoxic agents is indicated if there is evidence of active inflammation or a rapidly deteriorating course, although the benefit of such therapy is largely unproven.